Results 251 to 260 of about 188,935 (276)

Discovery of novel antibacterial agent for the infected wound treatment: all-hydrocarbon stapling optimization of LL-37. [PDF]

Theranostics
Zhang Y, Zheng M, Wang Z, Liu Z, Chen S, Li X, Shi Y, Hu H.   +7 more
europepmc   +1 more source

RNA Selectively Modulates Activity of Virulent Amyloid PSMα3 and Host Defense LL-37 via Phase Separation and Aggregation Dynamics

Rayan B, Barnea E, Indig R, Pantoja CF, Gayk J, Haber YL, Upcher A, Argoetti A, Larsen JA, Buell AK, Zweckstetter M, Landau M.   +11 more
europepmc   +1 more source

Complexation of fungal extracellular nucleic acids by host LL-37 peptide shapes neutrophil response to Candida albicans biofilm. [PDF]

Front Immunol
Juszczak M, Zawrotniak M, Rapala-Kozik M.   +2 more
europepmc   +1 more source

Correction to "Self-assembly of PEG-PPS polymers and LL-37 peptide nanomicelles improves the oxidative microenvironment and promotes angiogenesis to facilitate chronic wound healing". [PDF]

Bioeng Transl Med
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cathelicidin LL-37: A Multitask Antimicrobial Peptide

Archivum Immunologiae et Therapiae Experimentalis, 2010
The antimicrobial peptide LL-37 is the only known member of the cathelicidin family of peptides expressed in humans. LL-37 is a multifunctional host defense molecule essential for normal immune responses to infection and tissue injury. LL-37 peptide is a potent killer of different microorganisms with the ability to prevent immunostimulatory effects of ...
Robert, Bucki, Katarzyna, Leszczyńska, Andrzej, Namiot, Wojciech, Sokołowski   +3 more
openaire   +3 more sources

Cathelicidin LL-37 Expression in Human Breast Implant Capsules

Plastic & Reconstructive Surgery, 2023
Background: Capsular contracture is the most common complication following breast implant placement. Cathelicidin LL-37 is a cationic peptide involved in innate immunity. Initially investigated for its antimicrobial role, it was found to have pleiotropic activities, such as immunomodulation, angiogenesis stimulation, and tissue
Francesco, Segreto, Simone, Carotti, Giovanni Francesco, Marangi, Maria, Francesconi, Eleonora, Calia, Barbara, Cagli, Andrea, Cimmino, Caterina, Rossi, Sergio, Morini, Paolo, Persichetti   +9 more
openaire   +2 more sources

The chemistry and biology of LL-37

Natural Product Reports, 2009
LL-37 is a human host defence peptide that has a wide range of biological functions, including antimicrobial and immunomodulatory properties. This review summarises how molecular structure influences the balance between the immunomodulatory and antimicrobial functions of LL-37.
Matthew F, Burton, Patrick G, Steel
openaire   +2 more sources

Human Cathelicidin LL-37 Prevents Bacterial Biofilm Formation

Future Medicinal Chemistry, 2012
Human pathogens often colonize their host by the formation of biofilms. These surface-attached aggregates of bacteria are characterized by a self-produced extracellular matrix, which makes them highly resistant towards antibiotic treatment. Their abilities to adhere to abiotic surfaces (e.g., catheters and other medical devices) also makes bacterial ...
Andreas S, Jacobsen, Håvard, Jenssen
openaire   +2 more sources

LL-37-induced human osteoblast cytotoxicity and permeability occurs independently of cellular LL-37 uptake through clathrin-mediated endocytosis

Biochemical and Biophysical Research Communications, 2018
The host defense peptide LL-37 is cytotoxic for bacteria but it has also been reported to reduce host cell viability through an intracellular mechanism. LL-37-evoked cytotoxicity may be involved in the loss of bone tissue in periodontitis which is an inflammatory disease characterized by high concentrations of LL-37 observed locally in the periodontal ...
Emma Anders, Sara Dahl, Daniel Svensson, Bengt-Olof Nilsson   +3 more
openaire   +2 more sources